Rodrigo O. F.
- Country
- Spain
- Department
- Gynecology Service
Research Overview
- Efficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40
- A Prospective, Open-Label, Randomized, Interventional Study to Evaluate the Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women
Data & Insights
Has run more than one trial at 1 of 44 partner sites.
Specializations
Infectious Disease Research
This investigator specializes in the study of cytomegalovirus (CMV) infections, with particular emphasis on preventive medicine and vaccine development. Their research focuses on innovative approaches to protect against primary CMV infection.
- Viral Disease Prevention
- Vaccine Development
- Immunological Response
The investigator's work encompasses immunogenic responses in healthy populations, targeting young adults for preventive interventions.
Women's Health
The investigator demonstrates particular interest in female-specific preventive medicine, focusing on protecting women against viral infections. Their research examines targeted prevention strategies for women of reproductive age.
- Gender-Specific Prevention
- Reproductive Health Protection
- Preventive Healthcare
Their work particularly addresses the unique health needs and concerns of women regarding viral infection prevention.
Vaccine Immunology
The investigator concentrates on vaccine immunogenicity and protective responses, studying the effectiveness of novel vaccine technologies. Their research examines immune system responses to vaccination in young adult populations.
- Immune Response Analysis
- Vaccine Safety Assessment
- Preventive Medicine
Their work involves evaluating both the protective effects and safety profiles of new vaccine technologies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.